ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Planned Parenthood May Be Doing Harm By Selling Breast Cancer Screening to Women Under 40

February 10, 2012

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

NCI CTEP Approved Trials For the Month of December

December 27, 2013